NeuroBio
NeuroBio is revolutionizing drug discovery and development by applying AI, specifically Artificial Neural Networks (ANNs), to treat diseases. Their platform, NeuroAI™, uses ANNs to identify patterns and discover new drug target candidates for neurodegenerative diseases, aiming to engineer medicines rapidly and efficiently with an enhanced probability of success. The company emphasizes a patient-first approach and collaborates with leading pharmaceutical and technology companies, as well as academia, to accelerate outcomes. Their team comprises experts in biology, medicine, clinical pharmacology, applied mathematics, data science, AI, and software development, pushing boundaries in the field.
NeuroBio
NeuroBio is revolutionizing drug discovery and development by applying AI, specifically Artificial Neural Networks (ANNs), to treat diseases. Their platform, NeuroAI™, uses ANNs to identify patterns and discover new drug target candidates for neurodegenerative diseases, aiming to engineer medicines rapidly and efficiently with an enhanced probability of success. The company emphasizes a patient-first approach and collaborates with leading pharmaceutical and technology companies, as well as academia, to accelerate outcomes. Their team comprises experts in biology, medicine, clinical pharmacology, applied mathematics, data science, AI, and software development, pushing boundaries in the field.